Clinical Trials Browser

Phase 1 × Interventional × alovudine × Clear all

NCT01251874 2025-11-21

Veliparib and Carboplatin in Treating Patients With HER2-Negative Metastatic Breast Cancer

Phase 1 Active not recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02608216 2025-09-03

[18F]FLT PET/CT in Rb+ Metastatic Breast Cancer

Phase 1 Active not recruiting

Breast Neoplasms

NCT00880074 2023-06-26

FLT-PET in Predicting Response to Chemotherapy in Patients With Advanced Malignancies

Phase 1 Completed

Neoplasms

NCT00813566 2022-04-27

Multi-Tracer PET Assessment of Primary Brain Tumors

Phase 1 Completed

Brain Neoplasms, Neoplasms

NCT00633958 2021-10-20

FLT

Phase 1 Terminated

Disease, Central Nervous System Neoplasms

NCT02146222 2019-11-18

VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Docetaxel in Treating Patients With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT01480050 2019-05-22

Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma

Phase 1 Completed

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms

NCT00575393 2018-10-09

Gold Sodium Thiomalate in Treating Patients With Advanced Non-Small Cell Lung Cancer

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00499135 2017-10-10

Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors

Phase 1 Completed

Carcinoma, Renal Cell

NCT00553748 2008-07-03

Phase I, Open Label, Single Center Safety Study of [F-18]FLT

Phase 1 Completed

Brain Neoplasms